Seed Round - EpilepsyGTx
Investment Firm
Overview
EpilepsyGTx is a late-stage biotech company exploring cutting-edge gene therapies to improve the management of focal refractory epilepsy.
Announced Date
Jun 24, 2024
Funding Type
Seed
Highlights
N/A
Location
N/A
Social
N/A
Participant Investors
2
| Investor Name |
|---|
Round Details and Background
EpilepsyGTx raised $10000000 on 2024-06-24 in Seed Round
EpilepsyGTx is a late-stage biotech company exploring cutting-edge gene therapies to improve the management of focal refractory epilepsy.
Company Funding History
1
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 24, 2024 | 2 | - | 10.0M |
Recent Activity
News
Jul 02, 2024
Pulse 2.0 - EpilepsyGTx: $10 Million Raised To Develop Therapies For Treating Focal Refractory Epilepsy
News
Jun 26, 2024
36kr.com - EpilepsyGTx筹集1000万美元种子资金，开发基因疗法干预局灶性癫痫 | 海外New Things
News
Jun 26, 2024
EpilepsyGTx receives $10 million in seed funding
News
Jun 25, 2024
BioWorld Financial Watch - Seed funding at Epilepsygtx to advance gene therapy for focal refractory epilepsy
News
Jun 24, 2024
epilepsygtx.com - EpilepsyGTx announces a $10M fundraise to complete the CTA-enabling nonclinical package for lead program EPY201
News
Jun 24, 2024
BioSpace - EpilepsyGTx announces a $10M fundraise to complete the CTA-enabling nonclinical package for lead program EPY201